Tyrosine Kinase
Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
-
A3750 Regorafenib hydrochlorideTarget: Raf|VEGFR|PDGFR|c-Kit|c-RETSummary: Tyrosine kinase inhibitor
-
A3751 Regorafenib monohydrateSummary: Tyrosine kinase inhibitor
-
A3843 SU 5402Target: VEGFR|PDGFR|FGFRSummary: VEGFR2/FGFR/PDGFR/EGFR inhibitor
-
A3846 SU14813 maleateSummary: VEGFR/PDGFR/Kit/FLT-3 inhibitor
-
A3847 SU5416Target: VEGFRSummary: VEGF receptor inhibitor and AHR agonist
-
B2301 SAR131675Summary: VEGFR3 inhibitor,selective and ATP-competitve
-
B1494 Tyrphostin 9Summary: Selective EGFR/PDGFR inhibitor
-
A3870 TG 100801Target: VEGFR|FGFR|Src|Fyn kinaseSummary: Multi-kinase inhibitor
-
A3906 Vandetanib hydrochlorideSummary: VEGFR/EGFR inhibitor
-
A3009 Sorafenib2 CitationTarget: Raf|VEGFRSummary: Raf kinases and tyrosine kinases inhibitor